Literature DB >> 19283953

HCV in incarcerated populations: an analysis of gender and criminality on risk.

Anne G Rhodes1, Faye S Taxman, Peter D Friedmann, Karen L Cropsey.   

Abstract

While studies have explored the prevalence and correlates for hepatitis C (HCV) infection in substance-using and incarcerated populations these studies have not examined the attributes of criminal histories for those with HCV infection. This study examines the HCV infection rate as it relates to criminal risk factors using baseline data from a randomized trial of re-entering offenders and examines how these risk factors vary by gender. The HCV-positive population had a longer amount of time in confinement (105 vs. 61 months) than those who tested negative. HCV positive men were more likely to currently be receiving drug treatment than women. Criminal risk was positively associated with HCV infection while controlling for major risk factors (OR 1.25,95% CI: 1.07, 1.46), suggesting that the relationship was not spurious. While criminologists tend to examine risk relative to public safety threats, it appears that the public health needs equally require attention. Policy issues are examined regarding how services can be delivered to treat those with HCV infections within the correctional system and address criminal risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 19283953      PMCID: PMC3651872          DOI: 10.1080/02791072.2008.10400655

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  12 in total

1.  The disease profile of Texas prison inmates.

Authors:  J Baillargeon; S A Black; J Pulvino; K Dunn
Journal:  Ann Epidemiol       Date:  2000-02       Impact factor: 3.797

Review 2.  A framework for management of hepatitis C in prisons.

Authors:  Anne C Spaulding; Cindy M Weinbaum; Daryl T-Y Lau; Richard Sterling; Leonard B Seeff; Harold S Margolis; Jay H Hoofnagle
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

3.  Drug treatment services for adult offenders: the state of the state.

Authors:  Faye S Taxman; Matthew L Perdoni; Lana D Harrison
Journal:  J Subst Abuse Treat       Date:  2007-03-09

4.  The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Authors:  Theodore M Hammett; Mary Patricia Harmon; William Rhodes
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

5.  An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003.

Authors:  Jessica R MacNeil; Mark N Lobato; Marisa Moore
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

6.  Increasing voluntary HIV testing by offering oral tests in incarcerated populations.

Authors:  R L Bauserman; M A Ward; L Eldred; A Swetz
Journal:  Am J Public Health       Date:  2001-08       Impact factor: 9.308

7.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

8.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

9.  HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs.

Authors:  Kate Shannon; Melanie Rusch; Robert Morgan; Megan Oleson; Thomas Kerr; Mark W Tyndall
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

10.  Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system.

Authors:  J Baillargeon; H Wu; M J Kelley; J Grady; L Linthicum; K Dunn
Journal:  Public Health       Date:  2003-01       Impact factor: 2.427

View more
  6 in total

1.  Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates.

Authors:  Jaimie P Meyer; Javier Cepeda; Faye S Taxman; Frederick L Altice
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

Review 2.  HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings.

Authors:  Kristen Underhill; Dora Dumont; Don Operario
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

3.  A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.

Authors:  John T Nguyen; Josiah D Rich; Bradley W Brockmann; Fred Vohr; Anne Spaulding; Brian T Montague
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

4.  Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.

Authors:  Matthew J Akiyama; Fatos Kaba; Zachary Rosner; Howard Alper; Aimee Kopolow; Alain H Litwin; Homer Venters; Ross MacDonald
Journal:  Public Health Rep       Date:  2016-12-14       Impact factor: 2.792

5.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

6.  Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.

Authors:  Justin C Strickland; Michele Staton; Carl G Leukefeld; Carrie B Oser; J Matthew Webster
Journal:  Int J Prison Health       Date:  2018-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.